Fall 2019/Winter 2020 Issue
Dr. Ryutaro (Ryo) Hirose has been named Surgical Director of the Scientific Registry of Transplant Recipients (SRTR). As Surgical Director, Dr. Hirose will provide general surgical expertise to all aspects of SRTR, support the OPTN Board of Directors and committees, and serve as the primary surgical liaison to ASTS and other professional societies. He joins a leadership team that includes SRTR Medical Director and Deputy Director Dr. Ajay Israni, SRTR Medical Director for Living Donation Dr. Bertram Kasiske, and SRTR Director Dr. Jon Snyder. Dr. Hirose will continue in his role as Professor of Clinical Surgery at the University of California, San Francisco (UCSF) while lending his vast expertise to SRTR.
Yale New Haven Hospital’s Transplant Surgery APRN Joynell Mirasol (pictured left) received the ASTS APP Certificate of Educational Achievement “Joy is one of very few APPs in the country to have completed the ASTS certificate program,” said David Mulligan, MD, Chief of Transplantation and Immunology at Yale University School of Medicine.
Surgeons at Brigham and Women's Hospital in Boston performed the first full face transplant on an African American patient. 68-year-old Robert Chelsea was the recipient and became the ninth person at the Brigham, the 15th person in the United States, and the oldest person to undergo the procedure. The 16-hour surgery took place in July and involved a team of more than 45 physicians, nurses, anesthesiologists, residents, and research fellows. According to the team, Mr. Chelsea is "progressing and recovering remarkably fast."
Read the Brigham and Women’s Hospital’s press release on the surgery.
In August, surgeons at Cleveland Clinic performed the Midwest’s first purely laparoscopic living donor surgery for liver transplantation in an adult recipient. The advanced procedure is available at only a few hospitals worldwide, and Cleveland Clinic is the second U.S. academic medical center to offer this approach for living donor liver transplantation.
Choon Hyuck David Kwon, MD, PhD, Director of Laparoscopic Liver Surgery at Cleveland Clinic’s Digestive Disease & Surgery Institute, led a team of surgeons and nurses during the minimally invasive procedure that extracted a third of the liver from a 29-year-old living donor. Koji Hashimoto, MD, PhD, the Clinic’s Director of Living Donor Liver Transplantation, and his team received the donated segment of the liver and performed the transplant in a 66-year-old recipient.
“With the laparoscopic technique, the donor gets the benefits of minimally invasive surgery, resulting in shorter postoperative recovery time, less pain, better cosmetic results, and lower risk of an incisional hernia,” said Dr. Kwon.
Since the surgery, the Clinic has successfully performed the purely laparoscopic procedure on four more living liver donors.
On Wednesday, November 13, Matthew Cooper, MD, spoke on a panel at the Fixing Kidney Care event held by Politico in Washington, D.C. The panel discussed opportunities and challenges that are emerging among recent proposals to change kidney care in the U.S. Dr. Cooper is the Director of Kidney and Pancreas Transplantation at Medstar Georgetown Transplant Institute and serves as a Councilor-at-Large on the ASTS Council.
Tower Health announced in September that a new Tower Health Transplant Institute has been created and will become the new home for the nationally recognized kidney and liver transplant program formerly located at Hahnemann University Hospital.
Hahnemann’s transplant program team of renowned surgeons, hepatologists, and nephrologists have joined the Tower Health Medical Group and will serve West Reading and Philadelphia. The transplant team surgeons – who have performed more than 3,000 organ transplants – will perform kidney and liver transplants at the Reading Hospital HealthPlex. The team includes David J. Reich, MD, Medical Director of the Tower Health Transplant Institute and Professor of Surgery at Drexel University College of Medicine. Dr. Reich said, “our entire group is delighted to remain a team and to join the preeminent Tower Health system that is setting national standards for healthcare quality and patient satisfaction. We are deeply committed to excellence in clinical care, improving access to transplant services, and to the expanding academic mission of Tower Health."
Pending approval by UNOS, transplants could begin by the end of 2019.
The Health Resources and Services Administration (HRSA) announced Frank L. Holloman is now permanently the Director for the Division of Transplantation. Frank had served as the Acting Director since March 2018, and before that served as Deputy for the division. Prior to that, Frank worked with NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institute on Drug Abuse (NIDA).